Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.53 for the Quarter, an 18% Increase Over Prior Year Quarter; and $2.04 for the Year, a 27% Increase Over Prior Year
Date:2/21/2012

r 31, 2011, compared to $305.1 million for the comparable prior year period, an increase of $32.8 million, or 10.8%. Foreign currency translation had a negative impact on sales for the current quarter. Excluding the effect of foreign currency, calculated as described above, the increase was approximately $47 million, or 16%. This increase is primarily driven by higher third party sales from Mylan Laboratories Limited (formerly Matrix Laboratories Limited), Mylan's subsidiary in India, an increase in third party sales in Japan, as well as new product launches, mainly in Australia.

For the three months ended December 31, 2011, Mylan's Specialty segment reported third party net revenues of $104.7 million, an increase of $29.7 million, or 39.7%, from the comparable prior year period of $75.0 million. The most significant contributor to Specialty segment revenues continues to be the EpiPen® Auto-Injector, sales of which increased as a result of both favorable pricing and higher volumes. The EpiPen® Auto-Injector is the number one epinephrine auto-injector for the treatment of severe allergic reactions and maintains a market share in excess of 95% in the United States.

Gross profit for the three months ended December 31, 2011 was $644.6 million and gross margins were 42.1%.  In the comparable prior year period, gross profit was $579.2 million, and gross margins were 40.4%. Gross profit for the current and prior year periods were impacted by certain purchase accounting and other special items of approximately $87.6 million and $94.4 million, respectively, which consisted primarily of amortization related to purchased intangible assets.  Excluding such items, gross margins would have been approximately 48% and 47%, respectively. The increase in gross margins was primarily the result of new product introductions in North America and favorable pricing on the EpiPen® Auto-Injector.  

Earnings from operations were $2
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement
2. Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
3. Mylan Actively Addressing Shortage of Preservative-Free Methotrexate Injection
4. Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers
5. Mylan Completes Acquisition of Two Limited-Competition Dermatological Products from Valeant
6. Valeant Pharmaceuticals Completes Divestiture of Generic Dermatology Products to Mylan
7. Mylan Receives Tentative FDA Approval for Generic Version of Lipitor®
8. Mylan to Host Investor Day on Feb. 21, 2012, in New York City
9. Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
10. Mylan Launches First Generic Version of Teveten® Tablets
11. Mylan Receives Approval for First-to-File Generic Keppra XR® Extended-Release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Concord Medical Services Holdings Limited ("Concord Medical" ... leading specialty hospital management solution provider and operator of ... in China , today announced that ... a special cash dividend of US$0.30 per ordinary share ... Company,s outstanding ordinary shares. The total expense for the ...
(Date:7/28/2014)... , July 28, 2014 ... Ventures 2,5 Millionen £ investiert hat, um ... Konsumgüter-, Gesundheits-, Pharma- und Logistikbranche zu erfüllen. ...      (Photo: http://photos.prnewswire.com/prnh/20140728/697982 ) ... hat OmPrompt sein beschleunigtes Wachstum mit Investitionen ...
(Date:7/28/2014)... and NEW PROVIDENCE, N.J. ... engineering professionals are invited to meet with Linde,s Healthcare ... Technical Exhibition to be held at McCormick Place in ... "Hospitals demand nothing less than complete ... Mark Sanda , Linde,s Healthcare Segment manager. "Linde understands ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2Linde's Healthcare division to display new Hospital Services platform at the national ASHE Conference in Chicago 2
... BETHESDA, Md., Dec. 19, 2011 /PRNewswire-Asia/ -- Chindex International, ... care company providing health care services in China through ... private primary care hospitals and affiliated ambulatory clinics, today ... Hospital ("TJU"), one of the latest development projects of ...
...   , First once-daily, fixed-dose preventative treatment ... heartbeat) at risk of the devastating consequences of stroke ... solution for the treatment of deep vein thrombosis (DVT) ... is now approved in the UK for the prevention ...
Cached Medicine Technology:Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 2Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 3Chindex International, Inc. Announces Opening of Latest Premium Hospital in Tianjin 4Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 2Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 3Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 4Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 5Bayer's Xarelto® (rivaroxaban) Becomes First Fixed Dose Once-Daily Anticoagulant Tablet Approved in the UK for Stroke Prevention in non-valvular Atrial Fibrillation; and the First Single Drug Regimen for Deep Vein Thrombosis 6
(Date:7/28/2014)... (HealthDay News) -- Elementary school students seem to be satisfied ... to a new study of school officials. , , New ... -- went into effect in the fall of 2012. At ... lunch, or throw away most of their food. But the ... isn,t the case. , , "The updated meals standards are ...
(Date:7/28/2014)... 28, 2014 Thousands of DePuy Pinnacle ... of individuals who were allegedly injured by a metal-on-metal ... move forward in U.S. District Court, Northern District of ... issued on July 18, 2014, U.S. District Judge Ed ... the Plaintiffs’ Steering Committee that sought the deposition of ...
(Date:7/28/2014)... Cape Regional Medical Center, is currently ... solution in an effort to streamline its bi-directional ... their New Jersey health information exchange (NJSHINE). , ... New Jersey, serves the local population and more ... inpatient and outpatient services. With a strong commitment ...
(Date:7/28/2014)... chronic medical conditions people have at retirement age, the ... claims. Since nearly four in five older ... Bloomberg School of Public Health in Baltimore said the ... are slowing in the United States. "Living with ... heart failure is now the norm and not the ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July 28, 2014 ... irregularities are more likely to get a pacemaker than people ... study of more than 16,000 people found that those with ... a pacemaker than those without the memory-robbing condition. ... dementia are so much more likely to be treated with ...
Breaking Medicine News(10 mins):Health News:Healthy School Lunches Get Thumbs Up From Students 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 3
... , CHICAGO, Sept. 1 Controlling healthcare costs ... economic model to save our nation billions of dollars. , , ... answer, according to Jason Beans, CEO of Chicago-based Rising Medical Solutions ... change exists in a different direction. , , "People ...
... , Study is one of the first ... imaging techniques , , ... today announced the findings of a scientific study that used brain ... because it increases gray matter. Over a three-month period, adolescent girls ...
... , MORRISTOWN, N.J., Sept. 1 Prostate ... United States. In fact one in six men will face prostate cancer ... focus on an ongoing effort by Major League Baseball pitchers John ... of the Atlanta Braves, who are spreading the word about prostate cancer ...
... , KENILWORTH, N.J., Sept. 1 Schering-Plough Corporation (NYSE: ... the only 12-hour allergy medicine found in the allergy aisle. New ... the worst indoor and outdoor allergy symptoms. The product is ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090901/NY68186 ) ...
... , , , ... The maturity of the U.S. compression therapy market is ... plateau. Manufacturers are using the concept of evidence-based medicine to ... health awareness among consumers has spurred the demand for early ...
... VidaGas propane energy company secures $1.4M investment ... FRANCISCO, Sept. 1 VillageReach, the Seattle-based social enterprise that ... the Foundation for Community Development (FDC), a Mozambique non profit ... the Oasis Fund, a European commercial investment fund specializing in ...
Cached Medicine News:Health News:Five Ways to Change America's Healthcare System: 2Health News:Brain Imaging Shows Playing Tetris Leads to Both Brain Efficiency and Thicker Cortex 2Health News:Brain Imaging Shows Playing Tetris Leads to Both Brain Efficiency and Thicker Cortex 3Health News:Brain Imaging Shows Playing Tetris Leads to Both Brain Efficiency and Thicker Cortex 4Health News:Brain Imaging Shows Playing Tetris Leads to Both Brain Efficiency and Thicker Cortex 5Health News:Major League Baseball Pitchers John Smoltz and Derek Lowe Help Raise Awareness Throughout Prostate Cancer Awareness Month 2Health News:Major League Baseball Pitchers John Smoltz and Derek Lowe Help Raise Awareness Throughout Prostate Cancer Awareness Month 3Health News:Major League Baseball Pitchers John Smoltz and Derek Lowe Help Raise Awareness Throughout Prostate Cancer Awareness Month 4Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 2Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 3Health News:U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan 2Health News:U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan 3Health News:U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan 4Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 2Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 3Health News:VillageReach, Foundation for Community Development and Oasis Fund Announce Strategic Investment in Mozambique Social Business 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: